ArticleJournal of experimental orthopaedics2025
Tibio-tarsal arthrodesis in Italy: Results from an epidemiological 16-year nationwide study.
Article in Journal of experimental orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tibio-tarsal arthrodesis in Italy: Results from an epidemiological 16-year nationwide study.Journal of experimental orthopaedics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The goal of this study was to assess the annual incidence of tibiotarsal arthrodesis in Italy and the epidemiological characteristics of patients requiring surgery. A secondary aim was to assess the economic impact of this type of surgery on the healthcare system. Methods: The analysis was conducted by using the National Hospital Discharge Records (NHDR) database provided by the Italian Ministry of Health. Results: 8380 tibiotarsal arthrodeses were performed in Italy. One procedure per 100,000 adult Italians was the cumulative incidence. The age group of 60-64 years required the highest number of procedures. Males represented the majority of patients undergoing surgery (59.6%). The median length of hospital stay was 7.3 ± 10.8 days. On average, older patients had more days of hospitalization. Main primary diagnosis codes according to the ICD-9-CM were: 715.27 (17.5%); 905.4 (15.8%); 715.17 (11.7%); 716.17 (5.1%); 733.82 (3.9%); 718.47 (3.4%). The admission reimbursement in Italy ranges from 1887€ to 4405€ depending on the length of stay. In 16 years, a total expenditure of 36,803,844€ was projected. The procedure in Italy costed an average of 2,300,240 ± 373,514€ per year. Conclusions: The socioeconomic impact of tibiotarsal arthrodesis in Italy is relevant. Between 2001 and 2016, the frequency of this procedure progressively rose. Patients undergoing surgery in Italy are mainly men, still active and part of the working population. Nationwide epidemiologic studies are useful to understand the present and future development of the management of ankle diseases. Level of Evidence: Level III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.